Nucleolin Targeting AS1411 Modified Protein Nanoparticle for Antitumor Drugs Delivery

Effect of Surface Properties on Nanoparticle–Cell Interactions

Verma, A., & Stellacci, F. (2009) · Small · doi:10.1002/smll.200901158 · Cited by 2,621 · see citing works

Taxol stabilizes microtubules in mouse fibroblast cells.

Schiff, P. B., & Horwitz, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1561 · Cited by 1,971 · see citing works

[11] Calculation of protein conformation from circular dichroism

Yang, J. T., Wu, C. C., & Martínez, H. M. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)30013-2 · Cited by 1,644 · see citing works

Albumin-based nanoparticles as potential controlled release drug delivery systems

Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.031 · Cited by 1,526 · see citing works

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101 · see citing works

Taxol: A Novel Investigational Antimicrotubule Agent

Rowinsky, E. K., Cazenave, L. A., & Donehower, R. C. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.15.1247 · Cited by 1,096 · see citing works

Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer

Bates, P. J., Laber, D. A., Miller, D. M., Thomas, S. D., & Trent, J. O. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.004 · Cited by 874 · see citing works

Protein nanoparticles as drug carriers in clinical medicine

Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779 · see citing works

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 567 · see citing works

Sheddable Coatings for Long-Circulating Nanoparticles

Romberg, B., Hennink, W. E., & Storm, G. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 554 · see citing works

Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.

Gianni, L., Kearns, C. M., Giani, A., Capri, G., Viganò, L., Lacatelli, A., Bonadonna, G., & Egorin, M. J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.180 · Cited by 553 · see citing works

Molecular dissection of nucleolin's role in growth and cell proliferation: new insights

Srivastava, M., & Pollard, H. B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1911 · Cited by 495 · see citing works

Discovery and development of anticancer aptamers

Ireson, C. R., & Kèlland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481 · see citing works

In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size

Fang, C., Shi, B., Pei, Y., Hong, M., Wu, J., & Chen, H. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424 · see citing works

Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding

Bates, P. J., Kahlon, J. B., Thomas, S. D., Trent, J. O., & Miller, D. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26369 · Cited by 407 · see citing works

Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes

Cao, Z. C., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372 · see citing works

Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin

Shi, H., Huang, Y., Zhou, H., Song, X., Yuan, S., Fu, Y., & Luo, Y. (2007) · Blood · doi:10.1182/blood-2007-01-064428 · Cited by 257 · see citing works

The Cell-Surface-Expressed Nucleolin Is Associated with the Actin Cytoskeleton

Hovanessian, A. G., Puvion-dutilleul, F., Nisole, S., Svab, J., Perret, E., Deng, J., & Krust, B. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5071 · Cited by 244 · see citing works

Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides

Xu, X., Hamhouyia, F., Thomas, S. D., Burke, T. J., Girvan, A. C., McGregor, W. G., Trent, J. O., Miller, D. M., & Bates, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104446200 · Cited by 167 · see citing works

Development of aptamer therapeutics

Bunka, D. H. J., Platonova, O., & Stockley, P. G. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.06.009 · Cited by 152 · see citing works

Relating the phagocytosis of microparticles by alveolar macrophages to surface chemistry: the effect of 1,2-dipalmitoylphosphatidylcholine

Évora, C., Soriano, I., Rogers, R. A., Shakesheff, K. M., Hanes, J. S., & Langer, R. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00149-1 · Cited by 147 · see citing works

Antiproliferative Activity of G-Quartet-Forming Oligonucleotides with Backbone and Sugar Modifications

Đapić, V., Bates, P. J., Trent, J. O., Rodger, A., Thomas, S. D., & Miller, D. M. (2002) · Biochemistry · doi:10.1021/bi0119520 · Cited by 140 · see citing works

Influence of Preparation Methods on Solid State Supersaturation of Amorphous Solid Dispersions: A Case Study with Itraconazole and Eudragit E100

Janssens, S., Zeure, A. D., Paudel, A., Humbeeck, J. V., Rombaut, P., & den Mooter, G. V. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0069-y · Cited by 126 · see citing works

The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients

Masuya, D., Huang, C., Liu, D., Kameyama, K., Hayashi, E., Yamauchi, A., Kobayashi, S., Haba, R., & Yokomise, H. (2001) · Cancer · doi:10.1002/1097-0142(20011115)92:10 · Cited by 122 · see citing works

Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges

Singh, S., & Dash, A. K. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i4.10 · Cited by 102 · see citing works

Delivering cargoes into cancer cells using DNA aptamers targeting internalized surface portals

Orava, E. W., Cicmil, N., & Gariépy, J. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.02.004 · Cited by 89 · see citing works

Aptamer Applications for Targeted Cancer Therapy

Barbas, A. S., Mi, J., Clary, B. M., & White, R. R. (2010) · Future Oncology · doi:10.2217/fon.10.67 · Cited by 88 · see citing works

Molecular Switch For the Assembly of Lipophilic Drug Incorporated Plasma Protein Nanoparticles and In Vivo image

Gong, G., Xu, Y., Zhou, Y., Meng, Z., Ren, G., Zhao, Y., Zhang, X., Wu, J., & Hu, Y. (2011) · Biomacromolecules · doi:10.1021/bm201401s · Cited by 76 · see citing works

The amino terminus of mammalian nucleolin specifically recognizes SV40 T-antigen type nuclear localization sequences.

Xue, Z., Shan, X., Lapeyre, B., & Mélèse, T. (1993) · PubMed · Cited by 49 · see citing works

Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application

Liu, X., Lei, L., Hou, J., Tang, M.-F., Guo, S., Wang, Z., & Chen, K. (2011) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-010-4213-3 · Cited by 47 · see citing works

Phase I trial of cremophor EL with bolus doxorubicin.

Millward, M., Webster, L., Rischin, D., Stokes, K. H., Toner, G. C., Bishop, J. F., Olver, I., Linahan, B. Μ., Linsenmeyer, M. E., & Woodcock, D. M. (1998) · PubMed · Cited by 37 · see citing works

Enhanced antitumor efficacy of cisplatin by tirapazamine–transferrin conjugate

Wu, L., Wu, J., Zhou, Y., Tang, X., Du, Y., & Hu, Y. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.032 · Cited by 11 · see citing works

Smart Human Serum Albumin-Indocyanine Green Nanoparticles Generated by Programmed Assembly for Dual-Modal Imaging-Guided Cancer Synergistic Phototherapy

Sheng, Z., Hu, D., Zheng, M., Zhao, P., Liu, H., Gao, D., Gong, P., Gao, G., Zhang, P., Ma, Y., et al. (2014) · ACS Nano · doi:10.1021/nn5062386 · Cited by 719 · see citing works

Aptamers as Therapeutics

Nimjee, S. M., White, R. R., Becker, R. C., & Sullenger, B. A. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104558 · Cited by 616 · see citing works

Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies

Nounou, M. I., ElAmrawy, F., Ahmed, N., Abdelraouf, K., Goda, S., & Qhattal, H. S. S. (2015) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s29420 · Cited by 374 · see citing works

Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas

Li, L., Hou, J., Liu, X., Guo, Y., Wu, Y., Zhang, L., & Yang, Z. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.019 · Cited by 286 · see citing works

Hydrophobic IR780 encapsulated in biodegradable human serum albumin nanoparticles for photothermal and photodynamic therapy

Jiang, C., Cheng, H., Yuan, A., Tang, X., Wu, J., & Hu, Y. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.11.041 · Cited by 256 · see citing works

Capture-SELEX for aptamer selection: A short review

Lyu, C., Khan, I. M., & Wang, Z. (2021) · Talanta · doi:10.1016/j.talanta.2021.122274 · Cited by 254 · see citing works

Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing

Ku, T., Zhang, T., Luo, H., Yen, T., Chen, P., Han, Y., & Lo, Y. (2015) · Sensors · doi:10.3390/s150716281 · Cited by 242 · see citing works

Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy

Zhou, J., & Rossi, J. J. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.21 · Cited by 234 · see citing works

Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance

Liu, J., Wei, T., Zhao, J., Huang, Y., Deng, H., Kumar, A., Wang, C., Liang, Z., Ma, X., & Liang, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.013 · Cited by 208 · see citing works

Aptamers and Their Applications in Nanomedicine

Sun, H., & Zu, Y. (2015) · Small · doi:10.1002/smll.201403073 · Cited by 181 · see citing works

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy

Li, Z., Wang, Y., Shen, Y., Qian, C., Oupický, D., & Sun, M. (2020) · Science Advances · doi:10.1126/sciadv.aaz9240 · Cited by 171 · see citing works

Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells

Taghavi, S., Nia, A. H., Abnous, K., & Ramezani, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.027 · Cited by 152 · see citing works

Translatable High Drug Loading Drug Delivery Systems Based on Biocompatible Polymer Nanocarriers

Chen, W., Zhou, S., Ge, L., Wu, W., & Jiang, X. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00218 · Cited by 144 · see citing works

Impact of albumin based approaches in nanomedicine: Imaging, targeting and drug delivery.

Bhushan, B., Khanadeev, V., Khlebtsov, B., Khlebtsov, N., & Gopinath, P. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.06.012 · Cited by 112 · see citing works

AS1411 Aptamer and Folic Acid Functionalized pH-Responsive ATRP Fabricated pPEGMA–PCL–pPEGMA Polymeric Nanoparticles for Targeted Drug Delivery in Cancer Therapy

Lale, S. V., Girija, A. R., Aravind, A., Kumar, D. S., & Koul, V. (2014) · Biomacromolecules · doi:10.1021/bm5001263 · Cited by 125 · see citing works

Enhancement of Radiosensitization by Silver Nanoparticles Functionalized with Polyethylene Glycol and Aptamer As1411 for Glioma Irradiation Therapy

Zhao, J., Liu, P., Ma, J., Li, D., Yang, H., Chen, W., & Jiang, Y. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s224160 · Cited by 120 · see citing works

Aptamers as an approach to targeted cancer therapy

Mahmoudian, F., Ahmari, A., Shabani, S., Sadeghi, B., Fahimirad, S., & Fattahi, F. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03295-4 · Cited by 124 · see citing works

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy

Malik, M. T., O’Toole, M. G., Casson, L. K., Thomas, S. D., Bardi, G. T., Reyes‐Reyes, E. M., Ng, C. K., Kang, K. A., & Bates, P. J. (2015) · Oncotarget · doi:10.18632/oncotarget.4207 · Cited by 116 · see citing works

Relighting Photosensitizers by Synergistic Integration of Albumin and Perfluorocarbon for Enhanced Photodynamic Therapy

Ren, H., Liu, J., Su, F., Ge, S., Yuan, A., Dai, W., Wu, J., & Hu, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b14885 · Cited by 112 · see citing works

Anti-nucleolin aptamer AS1411: an advancing therapeutic

den Avont, A. V., & Sharma-Walia, N. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1217769 · Cited by 112 · see citing works

Transferrin/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma

Zhu, X., Zhou, H., Liu, Y., Wen, Y., Wei, C., Yu, Q., & Liu, J. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.10.012 · Cited by 104 · see citing works

Nucleolin-based targeting strategies for cancer therapy: from targeted drug delivery to cytotoxic ligands

Romano, S., Fonseca, N. A., Simões, S., Gonçalves, J., & Moreira, J. N. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.018 · Cited by 104 · see citing works

Advances in aptamer-mediated targeted delivery system for cancer treatment

He, S., Du, Y., Tao, H., & Duan, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124173 · Cited by 99 · see citing works

AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells

Ghahremani, F. H., Shahbazi‐Gahrouei, D., Kefayat, A., Motaghi, H., Mehrgardi, M. A., & Javanmard, S. H. (2018) · RSC Advances · doi:10.1039/c7ra11116a · Cited by 96 · see citing works

Topical formulations containing aptamer-functionalized nanocapsules loaded with 5-fluorouracil - An innovative concept for the skin cancer therapy

Raţă, D. M., Cadinoiu, A. N., Atanase, L. I., Popa, M., Mihai, C. T., Solcan, C., Ochiuz, L., & Vochița, G. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111591 · Cited by 92 · see citing works

Engineering Metal Nanoclusters for Targeted Therapeutics: From Targeting Strategies to Therapeutic Applications

Lin, Z., Goswami, N., Xue, T., Chai, O. J. H., Xu, H., Liu, Y., Su, Y., & Xie, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202105662 · Cited by 89 · see citing works

Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)–paclitaxel nanoconjugates

Luo, Z., Yan, Z., Jin, K., Pang, Q., Jiang, T., Lu, H., Liu, X., Pang, Z., Yu, L., & Jiang, X. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.12.004 · Cited by 87 · see citing works

Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer

Park, J. Y., Cho, Y. L., Chae, J. R., Moon, S. H., Cho, W. G., Choi, Y. J., Lee, S., & Kang, W. J. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.06.003 · Cited by 87 · see citing works

Plasmonic modulation of gold nanotheranostics for targeted NIR-II photothermal-augmented immunotherapy

Zhang, Y., Song, T., Feng, T., Wan, Y., Blum, N. T., Liu, C., Zheng, C., Zhao, Z., Jiang, T., Wang, J., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100987 · Cited by 80 · see citing works

Human anti-nucleolin recombinant immunoagent for cancer therapy

Palmieri, D., Richmond, T. K., Piovan, C., Sheetz, T. J., Zanesi, N. A. O., Troise, F., James, C. L., Wernicke, D., Nyei, F., Gordon, T. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507087112 · Cited by 80 · see citing works

Nucleolin targeting AS1411 aptamer modified pH-sensitive micelles for enhanced delivery and antitumor efficacy of paclitaxel

Zhang, J., Chen, R., Fang, X., Chen, F., Wang, Y., & Chen, M. (2015) · Nano Research · doi:10.1007/s12274-014-0619-4 · Cited by 78 · see citing works

Glutathione-activated DNA-Au nanomachine as targeted drug delivery platform for imaging-guided combinational cancer therapy

Yu, K., Hai, X., Yue, S., Song, W., & Bi, S. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.129535 · Cited by 76 · see citing works

Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery

Xu, L., He, X., Liu, B., Xu, C., Ai, S., Zhuo, R., & Cheng, S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.07.008 · Cited by 73 · see citing works

Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin

Liu, F., Mu, J., & Xing, B. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150302115411 · Cited by 70 · see citing works

AS1411 aptamer-targeted Gold Nanoclusters Effect on the Enhancement of Radiation Therapy Efficacy in Breast tumor-bearing Mice

Ghahremani, F., Kefayat, A., Shahbazi-Gahrouei, D., Motaghi, H., Mehrgardi, M. A., & Haghjooy-Javanmard, S. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0180 · Cited by 70 · see citing works

Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery

Cai, Y., Xu, Z., Shuai, Q., Zhu, F., Xu, J. H., Gao, X., & Sun, X. (2020) · Biomaterials Science · doi:10.1039/c9bm02036e · Cited by 69 · see citing works

Nucleolin-Targeting AS1411-Aptamer-Modified Graft Polymeric Micelle with Dual pH/Redox Sensitivity Designed To Enhance Tumor Therapy through the Codelivery of Doxorubicin/TLR4 siRNA and Suppression of Invasion

Yang, S.-D., Ren, Z., Chen, M., Wang, Y., You, B., Chen, W., Qu, C., Liu, Y., & Zhang, X. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b01093 · Cited by 66 · see citing works

Multifunctional ATRP based pH responsive polymeric nanoparticles for improved doxorubicin chemotherapy in breast cancer by proton sponge effect/endo-lysosomal escape

Lale, S. V., Kumar, A., Naz, F., Bharti, A. C., & Koul, V. (2015) · Polymer Chemistry · doi:10.1039/c4py01698j · Cited by 64 · see citing works

Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy

Ma, Y., Yu, S., Ni, S., Zhang, B., Kung, A. C. F., Gao, J., Lü, A., & Zhang, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626910 · Cited by 64 · see citing works

Applications of aptamers for chemistry analysis, medicine and food security

Huang, R., Xi, Z., & He, N. (2015) · Science China Chemistry · doi:10.1007/s11426-015-5344-7 · Cited by 62 · see citing works

Aptamers as smart ligands for nano-carriers targeting

Mokhtarzadeh, A., Tabarzad, M., Ranjbari, J., de la Guárdia, M., Hejazi, M., & Ramezani, M. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.06.018 · Cited by 60 · see citing works

Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs

Hassanin, I. A., & Elzoghby, A. O. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1813713 · Cited by 56 · see citing works

Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug

Battogtokh, G., Kang, J. H., & Ko, Y. T. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.07.013 · Cited by 54 · see citing works

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)

Thongchot, S., Aksonnam, K., Thuwajit, P., Yenchitsomanus, P., & Thuwajit, C. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5284 · Cited by 53 · see citing works

Self‐Assembled Aptamer‐Nanomedicine for Targeted Chemotherapy and Gene Therapy

Zhao, N., Zeng, Z., & Zu, Y. (2017) · Small · doi:10.1002/smll.201702103 · Cited by 53 · see citing works

T1–T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents

Li, J., You, J., Wu, C., Dai, Y., Shi, M., Dong, L., & Xu, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s168660 · Cited by 52 · see citing works

DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors

Shishparenok, A. N., Furman, V. V., & Zhdanov, D. D. (2023) · Cancers · doi:10.3390/cancers15072151 · Cited by 50 · see citing works

Mitochondrial-targeted photosensitizer-loaded folate-albumin nanoparticle for photodynamic therapy of cancer

Battogtokh, G., & Ko, Y. T. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.10.014 · Cited by 47 · see citing works

A two-component active targeting theranostic agent based on graphene quantum dots

Wang, X., Sun, X., He, H., Yang, H., Lao, J., Song, Y., Xia, Y., Xu, H., Zhang, X., & Huang, F. L. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00211g · Cited by 46 · see citing works

Dual-selective photodynamic therapy with a mitochondria-targeted photosensitizer and fiber optic cannula for malignant brain tumors

Kang, J. H., & Ko, Y. T. (2019) · Biomaterials Science · doi:10.1039/c9bm00403c · Cited by 46 · see citing works

Bifunctional Diblock DNA-Mediated Synthesis of Nanoflower-Shaped Photothermal Nanozymes for a Highly Sensitive Colorimetric Assay of Cancer Cells

Wei, Z., Yu, Y., Hu, S., Yi, X., & Wang, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c21109 · Cited by 45 · see citing works

Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics

Dobrovolskaia, M. A., & McNeil, S. E. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1042857 · Cited by 44 · see citing works

Meeting the needs of breast cancer: A nucleolin’s perspective

Gregório, A. C., Lacerda, M., Figueiredo, P., Simões, S., Dias, S., & Moreira, J. N. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.03.008 · Cited by 44 · see citing works

Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment

Liang, X., Wang, Y., Shi, H., Dong, M., Han, H., & Li, Q. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304526 · Cited by 41 · see citing works

The influencing factors and functions of DNA G‐quadruplexes

Yuan, W.-F., Wan, L.-Y., Peng, H., Zhong, Y., Cai, W.-L., Zhang, Y.-Q., Ai, W.-B., & Wu, J.-F. (2020) · Cell Biochemistry and Function · doi:10.1002/cbf.3505 · Cited by 32 · see citing works

A novel nanoparticle drug delivery system based on PEGylated hemoglobin for cancer therapy

Zhao, Y., Chen, G., Meng, Z., Gong, G., Zhao, W., Wang, K., & Liu, T. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1639846 · Cited by 40 · see citing works

Aptamer-Based In Vivo Therapeutic Targeting of Glioblastoma

Cesarini, V., Scopa, C., Silvestris, D. A., Scafidi, A., Petrera, V., Baldo, G. D., & Gallo, A. (2020) · Molecules · doi:10.3390/molecules25184267 · Cited by 39 · see citing works

Intelligent Tumor Microenvironment-Activated Multifunctional Nanoplatform Coupled with Turn-on and Always-on Fluorescence Probes for Imaging-Guided Cancer Treatment

Sun, Y., Wang, Y., Liu, Y., Weng, B., Yang, H., Xiang, Z., Ran, J., Wang, H., & Yang, C. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c17642 · Cited by 39 · see citing works

ATRP Fabricated and Short Chain Polyethylenimine Grafted Redox Sensitive Polymeric Nanoparticles for Codelivery of Anticancer Drug and siRNA in Cancer Therapy

Nehate, C., Raynold, A. A. M., & Koul, V. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b11716 · Cited by 38 · see citing works

Fabrication of aptamer modified TiO2 nanofibers for specific capture of circulating tumor cells

Liu, H., Sun, N., Ding, P., Chen, C., Wu, Z., Zhu, W., Liu, L., Wang, Z., & Pei, R. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110985 · Cited by 38 · see citing works

Simultaneous tracking of drug molecules and carriers using aptamer-functionalized fluorescent superstable gold nanorod–carbon nanocapsules during thermo-chemotherapy

Wang, X., Gao, W., Fan, H., Ding, D., Lai, X.-F., Zou, Y., Chen, L., Chen, Z., & Tan, W. (2016) · Nanoscale · doi:10.1039/c6nr00369a · Cited by 32 · see citing works

Comparative Assessment of Active Targeted Redox Sensitive Polymersomes Based on pPEGMA-S-S-PLA Diblock Copolymer with Marketed Nanoformulation

Nehate, C., Raynold, A. A. M., Haridas, V., & Koul, V. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00178 · Cited by 32 · see citing works

Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy

Sun, X., Liu, B., Chen, X., Lin, H., Peng, Y., Li, Y., Zheng, H., Xu, Y., Ou, X., Yan, S., et al. (2019) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-019-6278-y · Cited by 32 · see citing works

Aptamer–Pyropheophorbide a Conjugates with Tumor Spheroid Targeting and Penetration Abilities for Photodynamic Therapy

Xiong, H., Yan, J., Cai, S., He, Q., Wen, N., Wang, Y., Hu, Y., Peng, D., Liu, Y., & Liu, Z. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00335 · Cited by 32 · see citing works

Combinatorial delivery of superparamagnetic iron oxide nanoparticles (γFe 2 O 3 ) and doxorubicin using folate conjugated redox sensitive multiblock polymeric nanocarriers for enhancing the chemotherapeutic efficacy in cancer cells

Nehate, C., Alex, M. R. A., Kumar, A., & Koul, V. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.024 · Cited by 29 · see citing works

One-Step Self-Assembling Method to Prepare Dual-Functional Transferrin Nanoparticles for Antitumor Drug Delivery

Wang, K., Yuan, A., Yu, J., Wu, J., & Hu, Y. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.12.007 · Cited by 27 · see citing works

Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier

Gou, Y., Zhang, Y., Zhang, Z., Wang, J., Zhou, Z., Liang, H., & Yang, F. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01074 · Cited by 27 · see citing works

Self-assembly of an aptamer-decorated chimeric peptide nanocarrier for targeted cancer gene delivery

Dehghani, S., Alibolandi, M., Amiri‐Tehranizadeh, Z., Oskuee, R. K., Nosrati, R., Soltani, F., & Ramezani, M. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112047 · Cited by 27 · see citing works

Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate: Comparison with PEGylated liposomes

Han, S. Y., Sun, R., Su, H. H., Lv, J., Xu, H., Zhang, D., & Fu, Y. (2018) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2018.07.005 · Cited by 26 · see citing works

Development of drug-loaded protein nanoparticles displaying enzymatically-conjugated DNA aptamers for cancer cell targeting

Mie, M., Matsumoto, R., Mashimo, Y., Cass, A. E. G., & Kobatake, E. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4467-2 · Cited by 26 · see citing works

Nucleolin-targeted selenium nanocomposites with enhanced theranostic efficacy to antagonize glioblastoma

He, L., Zeng, L., Mai, X., Shi, C., Luo, L., & Chen, T. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb03365b · Cited by 25 · see citing works

Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au( i ) complex to cancer cells

Niu, W., Teng, I., Chen, X., Tan, W., & Veige, A. S. (2017) · Dalton Transactions · doi:10.1039/c7dt02616a · Cited by 25 · see citing works

Biomimetic Cancer Cell-Coated Albumin Nanoparticles for Enhanced Colloidal Stability and Homotypic Targeting of Breast Cancer Cells

Cao, Y., Yang, Y., Feng, S., & Wan, Y. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103698 · Cited by 24 · see citing works

Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma

Seo, K., Hwang, K., Nam, K. M., Kim, M. J., Shin, S., SONG, Y.-K., & Kim, C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040566 · Cited by 24 · see citing works

Organic additives stabilize RNA aptamer binding of malachite green

Zhou, Y., Chi, H., Wu, Y., Marks, R. S., & Steele, T. W. J. (2016) · Talanta · doi:10.1016/j.talanta.2016.06.067 · Cited by 23 · see citing works

Novel Complex of PD-L1 Aptamer and Holliday Junction Enhances Antitumor Efficacy in Vivo

Li, T., Yao, F., An, Y., Li, X., Duan, J., & Yang, X. (2021) · Molecules · doi:10.3390/molecules26041067 · Cited by 23 · see citing works

Synergistic Treatment of Tumor by Targeted Biotherapy and Chemotherapy via Site-Specific Anchoring of Aptamers on DNA Nanotubes

Chen, R., Sun, P., Chu, X., Pu, X., Yang, Y., Zhang, N., & Zhao, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s225142 · Cited by 23 · see citing works

Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets

Murphy, E. M., Centner, C. S., Bates, P. J., Malik, M. T., & Kopechek, J. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233466 · Cited by 23 · see citing works

Co-delivery of doxorubicin and AS1411 aptamer by poly(ethylene glycol)-poly(β-amino esters) polymeric micelles for targeted cancer therapy

Zhang, R., Wang, S.-B., Wu, W.-G., Kankala, R. K., Chen, A.-Z., Liu, Y.-G., & Fan, J.-Q. (2017) · Journal of Nanoparticle Research · doi:10.1007/s11051-017-3913-8 · Cited by 22 · see citing works

DNA Walker‐Regulated Cancer Cell Growth Inhibition

Li, F., Cha, T., Pan, J., Özçelikkale, A., Han, B., & Choi, J. H. (2016) · ChemBioChem · doi:10.1002/cbic.201600052 · Cited by 22 · see citing works

Folic acid-modified fluorescent dye-protein nanoparticles for the targeted tumor cell imaging

Xu, L., Jiang, G., Chen, H., Zan, Y., Hong, S., Zhang, T., Zhang, Y., & Pei, R. (2018) · Talanta · doi:10.1016/j.talanta.2018.10.094 · Cited by 21 · see citing works

Dynamics of delivering aptamer targeted nano-drugs into cells

Liu, Y., Yang, Y., Zhang, Q., Lu, D., Li, S., Li, J., Yang, G., & Shan, Y. (2021) · Journal of Materials Chemistry B · doi:10.1039/d0tb02527e · Cited by 21 · see citing works

Hybrid Cell-Penetrating Foldamer with Superior Intracellular Delivery Properties and Serum Stability

Douat, C., Bornerie, M., Antunes, S., Guichard, G., & Kichler, A. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00075 · Cited by 20 · see citing works

Targeting Host Cell Surface Nucleolin for RSV Therapy: Challenges and Opportunities

Mastrangelo, P., Norris, M. J., Duan, W., Barrett, E. G., Moraes, T. J., & Hegele, R. G. (2017) · Vaccines · doi:10.3390/vaccines5030027 · Cited by 19 · see citing works

Investigation of ultrafine gold nanoparticles (AuNPs) based nanoformulation as single conjugates target delivery for improved methotrexate chemotherapy in breast cancer

Naz, F., Dinda, A. K., Kumar, A., & Koul, V. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118561 · Cited by 19 · see citing works

Novel nanosized AS1411–chitosan–BODIPY conjugate for molecular fluorescent imaging

Taki, S., & Ardestani, M. S. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s202561 · Cited by 18 · see citing works

Noncovalent tethering of nucleic acid aptamer on DNA nanostructure for targeted photo/chemo/gene therapies

Shim, G., Park, J.-W., Kim, M., Yang, G., Lee, Y. J., & Oh, Y. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102053 · Cited by 18 · see citing works

AS1411-functionalized delivery nanosystems for targeted cancer therapy

Kozani, P. S., Kozani, P. S., & Malik, M. T. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00039 · Cited by 18 · see citing works

Synthesis, characterization and biocompatibility evaluation of iron oxide incorporated magnetic mesoporous silica

Gandhi, S., Sethuraman, S., & Krishnan, U. M. (2012) · Dalton Transactions · doi:10.1039/c2dt30853c · Cited by 17 · see citing works

Drug delivery mediated by confined nanosystems: structure-activity relations and factors responsible for the efficacy of formulations

Zakharova, L. Y., Pashirova, T. N., Kashapov, R. R., Gabdrakhmanov, D. R., & Sinyashin, O. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00024-5 · Cited by 17 · see citing works

AS1411 aptamer based nanomaterials: A novel approach for breast cancer therapy

Verma, Y., Khan, I., Dongsar, T. T., Alsayari, A., Wahab, S., Sahebkar, A., & Kesharwani, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145125 · Cited by 16 · see citing works

Formulation optimization of lyophilized aptamer-gold nanoparticles: Maintained colloidal stability and cellular uptake

Saidi, D., Obeidat, M., Alsotari, S. T., Ibrahim, A. A., Albuqain, R., Wehaibi, S., Alqudah, D. A., Nsairat, H., Alshaer, W., & Alkilany, A. M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30743 · Cited by 16 · see citing works

Advances in nanoparticle mediated targeting of RNA binding protein for cancer

Kashikar, R., Kotha, A. K., Shah, S., Famta, P., Singh, S. B., Srivastava, S., & Chougule, M. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114257 · Cited by 16 · see citing works

Heritable modifiers of the tumor microenvironment influence nanoparticle uptake, distribution and response to photothermal therapy

Sharma, G., Jagtap, J. M. M., Parchur, A. K., Gogineni, V. R., Ran, S., Bergom, C. R., White, S. B., Flister, M. J., & Joshi, A. (2020) · Theranostics · doi:10.7150/thno.41171 · Cited by 15 · see citing works

Nanoparticles Functionalized with Ligands of Cell Surface Nucleolin for Cancer Therapy and Diagnosis

Sader, M. (2015) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000310 · Cited by 14 · see citing works

G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection

Leaderer, D., Cashman, S., & Kumar-Singh, R. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.02.009 · Cited by 12 · see citing works

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection

Pålsson, S. A., Dondalska, A., Bergenstråhle, J., Rolfes, C., Björk, A., Sedano, L., Power, U. F., Rameix‐Welti, M., Lundeberg, J., Wahren‐Herlenius, M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580547 · Cited by 12 · see citing works

Paclitaxel modified Fe 3 O 4 loaded albumin nanoparticles as drug delivery vehicles by self-assembly

Tang, X., Ben-lan, L., Cui, S., Zhang, X., Yang, Z., Wu, Q., Zhang, X., Shen, X., & Wang, T. (2016) · RSC Advances · doi:10.1039/c6ra04659b · Cited by 11 · see citing works

Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells

Leandro, L. D., Giansanti, F., Mei, S., Ponziani, S., Colasante, M., Ardini, M., Angelucci, F., Pitari, G., d’Angelo, M., Cimini, A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.588306 · Cited by 11 · see citing works

AS1411 Aptamer-Mediated Targeted Drug Delivery of Doxorubicin-loaded PLGA Nanoparticles to Cancer Cells through Cell Surface Nucleolin

Mosafer, J., & Bazrafshan, E. (2017) · Journal of Torbat Heydariyeh University of Medical Sciences

Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells

Mosafer, J., & Mokhtarzadeh, A. (2018) · Current Drug Delivery · doi:10.2174/1567201815666180724104451 · Cited by 36 · see citing works

Targeted Delivery of Paclitaxel-Loaded Polycaprolactone Nanoparticles Via AS1411 Aptamer for Enhanced Uptake in Nucleolin-Expressing Prostate and Breast Cancer Cells

Tarin, M., Etemad, S., Oryani, M. A., Ebadi, A., Efati, Z., Javid, H., & Karimi‐Shahri, M. (2026) · Journal of Cluster Science · doi:10.1007/s10876-026-03120-0

Chemotherapeutic, Toxin, and Therapeutic Protein Delivery via Nucleolin Aptamer-functionalized Nanoplatforms for Targeted Cancer Therapy

Kozani, P. S., Kozani, P. S., & Rahbarizadeh, F. (2021) · Trends in Medical Sciences · doi:10.5812/tms.113773 · Cited by 2 · see citing works

AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery

Aravind, A., Jeyamohan, P., Nair, R., Veeranarayanan, S., Nagaoka, Y., Yoshida, Y., Maekawa, T., & Kumar, D. S. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24558 · Cited by 193 · see citing works